SQZ Biotech has a promising new way of transforming cell behavior. This technology from MIT’s storied Langer Lab is backed by a $500 Million collaboration with Roche, the biggest maker of cancer drugs, and $24 million in VC money.
Sal Daher, CFA, together with other angels, is an investor in SQZ Biotech. To learn more about investing alongside Sal and his colleagues in this type of startup please enter your email address:
Investments in Startups are Inherently Risky. Such investments should only be undertaken by financially sophisticated persons who are accredited investors as defined under US securities laws and who are capable of bearing the risks involved. Do seek independent investment advice in making your decision to invest. We do not provide investment advice.
LISTEN TO SAL’S INTERVIEW OF ARMON SHAREI, CEO OF SQZ BIOTECH HERE
CURRENT PODCAST EPISODE
A New Podcast EpisodE IS Released Every Wednesday.
DACA recipient, Berkeley grad, and a Googler, Victor Santos is not a typical startup founder. His Boston-based startup, Airfox is addressing a huge problem: access to affordable financing in Latin America. Through a partnership with one of Brazil’s leading retail lenders, Airfox is able to gather data that enables lower-cost lending in a country where consumers routinely pay interest rates of 400% per annum.
New episodes released every Wednesday. Subscribe to our podcast on iTunes to make certain you never miss an episode: